TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $20,000 | +5.3% | 1,178 | +16.6% | 0.00% | 0.0% |
Q1 2021 | $19,000 | +26.7% | 1,010 | +21.1% | 0.00% | 0.0% |
Q4 2020 | $15,000 | -6.2% | 834 | -6.5% | 0.00% | 0.0% |
Q3 2020 | $16,000 | -5.9% | 892 | -3.1% | 0.00% | -25.0% |
Q2 2020 | $17,000 | +183.3% | 921 | +125.2% | 0.00% | +100.0% |
Q1 2020 | $6,000 | -66.7% | 409 | -56.8% | 0.00% | -50.0% |
Q4 2019 | $18,000 | +100.0% | 947 | +83.2% | 0.00% | +100.0% |
Q3 2019 | $9,000 | +80.0% | 517 | +64.1% | 0.00% | +100.0% |
Q2 2019 | $5,000 | -54.5% | 315 | -43.8% | 0.00% | -50.0% |
Q1 2019 | $11,000 | – | 560 | +5500.0% | 0.00% | – |
Q4 2018 | $0 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |